2 days.

Why It Matters as a Performance Indicator

Delayed query resolution has a cascading effect on many aspects of clinical trials:

• ⏳ Delays in Database Lock: Unresolved queries block final data cleaning steps.
• ⚠️ Risk of Regulatory Findings: Agencies like USFDA and CDSCO expect timely query handling.
• 📉 Low Site Ranking: CROs and sponsors rate site performance using this KPI.
• 📊 Trial Timeline Extensions: Slow query responses may require study deadline adjustments.

How to Calculate Query Resolution Time

Query resolution time can be calculated with the following formula:

Query Resolution Time = (Date of Query Closure – Date of Query Issuance)

This can be reported per query, per patient, or averaged across all queries for a site. Commonly, metrics are presented in the following formats:

• 📈 Average resolution time per query (in days)
• 📉 % of queries resolved within SLA (e.g., 2 working days)
• 🧮 Number of open vs. closed queries per site

Industry Benchmarks for Query Resolution

While benchmarks vary by trial phase and therapeutic area, common expectations include:

• ✔ 90% of queries resolved within 2–3 working days
• ✔ No query older than 5 working days without documented justification
• ✔ First response to query within 48 hours

Sites consistently missing these thresholds may require retraining or increased oversight.

Factors Affecting Query Resolution Times

• 👩‍⚕️ Investigator availability
• 📉 Staff training and understanding of protocol/data fields
• 📋 Query volume and complexity
• 📡 Internet connectivity and EDC system reliability
• ⏲ Internal site workflow and documentation practices

High-performing sites typically have designated CRCs (Clinical Research Coordinators) responsible for daily review of the EDC system and prompt query responses.

Tools for Tracking Query Resolution Metrics

Most CROs and sponsors use dashboards and real-time analytics tools built into their EDC or CTMS (Clinical Trial Management System) platforms to monitor query activity. These dashboards often feature:

• 📊 Query aging reports
• 📈 Heatmaps highlighting high-burden sites
• 📆 Turnaround time trends over months
• 🔔 Alerts for overdue queries

These tools can support sponsors in site selection and identify areas for improvement in ongoing studies. For example, Stability Studies also use similar data quality dashboards to meet regulatory expectations.

Integrating into Site Performance Review

Query resolution time should be a component of your site performance review, along with other KPIs like:

• 📌 Enrollment rate
• 📌 Protocol deviation frequency
• 📌 SDV (Source Data Verification) completion
• 📌 Monitor visit findings

Sites with poor query metrics may be subject to increased monitoring frequency, mandatory CAPAs, or even replacement in multicenter trials.

CAPA and Continuous Improvement

If query resolution metrics fall below expectations, implement CAPA steps such as:

1. 🧠 Retrain site staff on data entry and query resolution procedures
2. 📋 Introduce query resolution SOPs with timelines
3. 📆 Establish daily data review responsibilities
4. 📞 Schedule weekly data review calls with the CRA
5. 📈 Monitor improvements via monthly query closure reports

Documentation of CAPA should be retained as part of the TMF and reflected in Pharma SOPs as part of site management documentation.

Regulatory Expectations

Regulatory authorities including EMA and TGA expect sponsors to demonstrate data oversight throughout the trial. Delayed or missing query closures are often cited in GCP inspection findings.

Query resolution performance can influence:

• 🔍 Audit readiness
• 📂 Data lock timelines
• 📝 Final Clinical Study Report (CSR) preparation

Conclusion

Query resolution time is more than a metric—it reflects a site’s efficiency, attention to data quality, and commitment to protocol compliance. It should be closely tracked, benchmarked, and addressed proactively as part of ongoing site oversight.

By integrating query metrics into your performance dashboards and SOPs, you ensure cleaner data, faster timelines, and higher regulatory confidence throughout the trial lifecycle.